COMMUNIQUÉS West-GlobeNewswire

Eton Pharmaceuticals Enters Into License Agreement for Two Branded Hospital Product Candidates

11/02/2019 - 14:01

Transaction adds an additional potential 2019 product launch to Eton’s pipeline ET-202 NDA was submitted in December 2018; PDUFA date expected to be in Q4 2019 ET-203 NDA expected to be submitted by Q3 2019 DEER PARK, [...]

Nemaura Announces Dr. Fred Schaebsdau to Lead Strategy and Business Development

11/02/2019 - 14:00

Dr. Schaebsdau to Advance European Launch of SugarBEAT ® Continuous Glucose Monitor Nemaura Preparing U.S. FDA 510(k) Submission Loughborough, England – February 11, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) [...]

CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer

11/02/2019 - 14:00

CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical announces the appointment of Ingeborg Øie as Chief Financial Officer Cambridge, UK, 11 February 2019 : CMR Surgical Ltd, the British company developing [...]

Delcath Announces Health Authority Approval for CHEMOSAT in Brazil

11/02/2019 - 14:00

Discussions Underway With Potential Commercialization Partners NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and [...]

IntelGenx Granted Japanese Patent for RIZAPORT® VersaFilm™

11/02/2019 - 14:00

SAINT LAURENT, Quebec, Feb. 11, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has received a Decision to Grant notice from [...]

CLS Holdings USA Inc. Included in LD Micro Index Rebalance

11/02/2019 - 14:00

LAS VEGAS, Feb. 11, 2019 (GLOBE NEWSWIRE) -- CLS Holdings USA Inc. (OTCQB:CLSH) (CSE:CLSH.U) “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce that it has been included in [...]

BLOCKStrain Taps into the CBD Beverage Industry with NXT Water Deal -- CFN Media

11/02/2019 - 14:00

SEATTLE, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Allakos Announces Positive Phase 2 Results for AK002 in Patients with Xolair Refractory Chronic Spontaneous Urticaria and Provides Additional Data from Chronic Urticaria Study Cohorts

11/02/2019 - 14:00

-- 55% (6/11) response rate by UCT in Xolair Refractory CSU patients -- -- 49% reduction in UAS7 in Xolair Refractory CSU patients -- -- 77% (10/13) complete hive response by HSS7 in Xolair Naïve CSU patients -- -- 54 [...]

Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for the Treatment of Relapsed and Refractory Melanoma

11/02/2019 - 14:00

BERKELEY, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that the first patient has been dosed in a Phase 1 trial of ADU-S100 (MIW815), a novel stimulator of interferon [...]

Tauriga Sciences, Inc. Implements Quality Assurance Protocols Within the Manufacturing Process of its CBD Infused Gum

11/02/2019 - 14:00

NEW YORK, NY, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]

Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial

11/02/2019 - 13:45

-- Substudy promptly accrued 36 patients in less than six months, with majority of newly enrolled patients receiving low-dose steroids -- BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) [...]

Theratechnologies Appoints General Manager in Europe

11/02/2019 - 13:30

MONTREAL, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that its European subsidiary, Theratechnologies International Limited, has appointed Mr. Conor [...]

Theratechnologies Nomme un Directeur Général en Europe

11/02/2019 - 13:30

MONTRÉAL, 11 févr. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que sa filiale européenne, Theratechnologies International Limitée, a nommé M. Conor Walshe à [...]

Agile Therapeutics, Inc. Announces that Twirla® Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane®

11/02/2019 - 13:30

Company now focused on completing plan to resubmit NDA in first half of 2019 PRINCETON, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced [...]

Helix BioPharma Corp. Provides Clinical Development and Strategic Corporate Update

11/02/2019 - 13:30

RICHMOND HILL, Ontario, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Avenue Therapeutics Announces First Stage Closing of its Acquisition Agreement with InvaGen (a Cipla subsidiary)

11/02/2019 - 13:30

NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a Fortress Biotech (NASDAQ: FBIO) company, today announced the completion of the first stage closing of the Acquisition [...]

Nephros Appoints Alisa Lask to its Board of Directors

11/02/2019 - 13:30

SOUTH ORANGE, NJ, Feb. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, [...]

TYME Reports Third Quarter Fiscal 2019 Financial and Operating Results

11/02/2019 - 13:30

TYME’s novel metabolic-based investigational cancer therapy, SM-88, demonstrated encouraging results and a well-tolerated safety profile in a preliminary analysis from a Phase II study of patients with advanced [...]

Arcturus Therapeutics to Present at Upcoming Investor Conferences

11/02/2019 - 13:05

SAN DIEGO, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics towards rare, infectious, fibrotic [...]